La Presse Médicale Formation最新文献

{"title":"Ours redaction","authors":"","doi":"10.1016/S2666-4798(25)00077-1","DOIUrl":"10.1016/S2666-4798(25)00077-1","url":null,"abstract":"","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 3","pages":"Article 100671"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Interprétation d’une anomalie de la chlorémie","authors":"Jérémy Zaworski , François Vrtovsnik","doi":"10.1016/j.lpmfor.2025.100667","DOIUrl":"10.1016/j.lpmfor.2025.100667","url":null,"abstract":"","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 3","pages":"Article 100667"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prescription des statines en prévention primaire : de grandes disparités en fonction du mode de calcul du risque","authors":"Jean-François Renucci ,&nbsp;Barbara Leclercq ,&nbsp;Gabrielle Sarlon","doi":"10.1016/j.lpmfor.2025.100604","DOIUrl":"10.1016/j.lpmfor.2025.100604","url":null,"abstract":"<div><div>La prescription d’une statine ne se discute plus en prévention secondaire. En prévention primaire, il est conseillé d’instaurer un traitement en fonction du niveau de risque cardiovasculaire du patient. Mais, il existe de nombreuses méthodes d’évaluation de ce risque et les résultats sont discordants en fonction de celle utilisée. C’est le modèle européen SCORE 2 qui semble le plus adapté pour aider à faire ce choix. Toutefois, l’instauration d’un traitement ne saurait reposer uniquement sur un chiffre mais sur l’ensemble de la situation clinique. Ce résultat, certes très utile, n’est qu’un élément parmi d’autres qui doit intervenir dans la décision partagée avec le patient.</div></div><div><div>The prescription of a statin is no longer discussed for secondary prevention. In primary prevention, it is advisable to initiate treatment according to the patient's level of cardiovascular risk. But there are many methods of assessing this risk and the results are discordant depending on the one used. It is the European SCORE2 model which seems most suitable to help make this choice. However, the initiation of treatment cannot be based solely on a figure but on the entire clinical situation. This result, certainly very useful, is only one element among others which must be involved in the decision shared with the patient.</div></div>","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 3","pages":"Article 100604"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sommaire","authors":"","doi":"10.1016/S2666-4798(25)00078-3","DOIUrl":"10.1016/S2666-4798(25)00078-3","url":null,"abstract":"","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 3","pages":"Article 100672"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"La prescription des statines en prévention primaire","authors":"Jean-François Renucci ,&nbsp;Barbara Leclercq ,&nbsp;Gabrielle Sarlon","doi":"10.1016/j.lpmfor.2025.100603","DOIUrl":"10.1016/j.lpmfor.2025.100603","url":null,"abstract":"","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 3","pages":"Article 100603"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"CV1 / Sommaire","authors":"","doi":"10.1016/S2666-4798(25)00075-8","DOIUrl":"10.1016/S2666-4798(25)00075-8","url":null,"abstract":"","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 3","pages":"Article 100669"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Quelle place pour le Holter ECG en cardiologie en 2025 à l’ère des objets connectés ? Quand le proposer ? Quel Holter pour quel patient ?","authors":"J. Timnou Bekouti ,&nbsp;C. Kouakam","doi":"10.1016/j.lpmfor.2025.100665","DOIUrl":"10.1016/j.lpmfor.2025.100665","url":null,"abstract":"&lt;div&gt;&lt;div&gt;L’enregistrement ambulatoire de l’électrocardiogramme (ECG), de manière continue durant 24 à 72&lt;!--&gt; &lt;!--&gt;h (Holter ECG standard), ou séquentielle durant 3 semaines (enregistreur d’évènements externe), voire plusieurs mois ou années (Holter implantable), a contribué à l’amélioration de la détection des troubles du rythme paroxystiques chez des patients avec palpitations, lipothymie ou syncope, de la fibrillation atriale (FA) infraclinique après un accident vasculaire cérébral (AVC) inexpliqué, et également aidé à la stratification du risque rythmique dans certaines cardiopathies acquises ou héréditaires. Quelle que soit la méthode d’enregistrement utilisée, de nombreuses études ont démontré que la rentabilité diagnostique est directement corrélée à la durée d’enregistrement. De ce fait le Holter ECG standard est de plus en plus délaissé au profit du Holter implantable dans le bilan des syncopes inexpliquées et pour le screening de la FA après un AVC cryptogénique, et par les enregistreurs d’évènements chez les patients avec palpitations non documentées. Le Holter classique conserve malgré tout une place de choix dans l’évaluation de l’efficacité d’un traitement électrique ou pharmacologique des arythmies, ou de la moyenne nycthémérale de la fréquence cardiaque et sa variabilité. Ces dernières années, de nombreux dispositifs connectés portatifs disposant parfois d’une possibilité de tracé ECG ont vu le jour et connu un développement fulgurant. Une amélioration significative de la détection des arythmies se profile car ces outils peuvent dans certaines indications (palpitations non documentées) trouver un champ d’application intéressant. Néanmoins la multiplication des données générées par tous ces dispositifs connectés « intelligents » pose la question de la responsabilité de leur gestion et de la pertinence clinique apportée.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;Ambulatory electrocardiogram (ECG) recording, either continuously for 24 to 72&lt;!--&gt; &lt;!--&gt;hours (standard Holter ECG), or sequentially for 3 weeks (external loop recorder), or even several months or years (implantable Holter), has contributed to improving the detection of paroxysmal rhythm disorders in patients with palpitations, lipothymia, or syncope, subclinical atrial fibrillation (AF) after unexplained stroke, and also helped in rhythm risk stratification in some acquired or inherited heart diseases. Regardless of the recording method used, numerous studies have demonstrated that diagnostic yield is directly correlated with recording duration. As a result, standard Holter ECG is increasingly being abandoned in favor of the implantable Holter in the assessment of unexplained syncope and for screening of AF after cryptogenic stroke, and by loop recorders in patients with undocumented palpitations. Standard Holter nevertheless retains a place of choice in the evaluation of the effectiveness of electrical or pharmacological treatment of cardiac arrhythmias, or of the nychthemeral mean of the he","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 3","pages":"Article 100665"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrigendum à l’article « Alerte obésité » [Presse Med Form 6 (2025) 100592]","authors":"Jean-Michel Lecerf (Endocrinologue)","doi":"10.1016/j.lpmfor.2025.100663","DOIUrl":"10.1016/j.lpmfor.2025.100663","url":null,"abstract":"","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 3","pages":"Article 100663"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Les maladies rénales ont elles des spécificités chez la femme ?","authors":"B. Julie ,&nbsp;A. Hamroun ,&nbsp;C.-L. de Sainte Foy ,&nbsp;J. Delannoy ,&nbsp;M. Fericot ,&nbsp;C. Lebas ,&nbsp;F. Provot ,&nbsp;C. Mounier-Vehier ,&nbsp;F. Glowacki ,&nbsp;M. Frimat","doi":"10.1016/j.lpmfor.2025.100666","DOIUrl":"10.1016/j.lpmfor.2025.100666","url":null,"abstract":"<div><div>Les maladies rénales chroniques (MRC) affectent environ 12 % des femmes dans le monde, avec des spécificités de causes et de prise en charge, motivant de récentes initiatives internationales pour améliorer la compréhension et développer les pratiques de dépistage et de suivi. Les particularités biologiques et hormonales féminines influencent la fonction rénale et vasculaire. La grossesse, en tant qu’événement supra-physiologique peut révéler des susceptibilités sous-jacentes aux maladies rénales, tandis que la ménopause accentue le risque rénal et cardiovasculaire. Les complications obstétricales, comme la prééclampsie et l’insuffisance rénale aiguë liée à la grossesse, sont associées à un risque accru de MRC, d’albuminurie persistante et d’hypertension artérielle chronique, soulignant l’intérêt d’un suivi. Les moments clés de la vie féminine – contraception, grossesse, ménopause – offrent des opportunités pour dépister les pathologies rénales et prévenir les complications à long terme. L’identification des risques rénaux spécifiques aux femmes reste freinée par un manque de données différenciées selon le sexe et une sous-représentation féminine dans les essais cliniques. Une meilleure intégration de ces spécificités dans la recherche et les pratiques cliniques pourrait améliorer la prévention et la prise en charge des MRC.</div></div><div><div>Chronic kidney disease (CKD) affects approximately 12% of women worldwide, with specific causes and management strategies that have prompted international initiatives to improve understanding and harmonize screening and follow-up practices Biological and hormonal differences in women impact renal and vascular function. Pregnancy, as a supra-physiological event, can unmask underlying renal susceptibilities, while menopause amplifies renal and cardiovascular risks. Obstetric complications, such as preeclampsia and pregnancy-related acute kidney injury (AKI), are associated with an increased risk of CKD, persistent albuminuria, and chronic hypertension, underscoring the importance of follow-up care. Key stages of a woman's life — contraception, pregnancy, and menopause — provide critical opportunities for identifying renal pathologies and preventing long-term complications. The identification of kidney-specific risks in women is hindered by a lack of sex-disaggregated data and the underrepresentation of women in clinical trials. Better integration of these sex-specific considerations into research and clinical practice could enhance CKD prevention and management.</div></div>","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 3","pages":"Article 100666"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sommaire","authors":"","doi":"10.1016/S2666-4798(25)00050-3","DOIUrl":"10.1016/S2666-4798(25)00050-3","url":null,"abstract":"","PeriodicalId":100859,"journal":{"name":"La Presse Médicale Formation","volume":"6 2","pages":"Article 100644"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143687709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}